🟢 Neurosense Therapeutics is trading 5.94% up today — catalyst remains unclear

Neurosense Therapeutics is trading 5.94% up at $0.48, with the catalyst unclear on August 17, 2026.

• No new company-specific announcement has been identified.
• The latest material update was an August 13 CEO letter saying financing for the Phase 3 PARAGON ALS study was taking longer than expected and discussing Nasdaq compliance measures.
• The broader market is nearly flat and does not clearly explain the move.